BioGaia
107.00 SEK
-0.37 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.37 %
-7.28 %
+0.75 %
+7.81 %
+2.49 %
-13.71 %
+7.54 %
+26.18 %
+1,406.34 %
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.
Read moreMarket cap
10.82B SEK
Turnover
3.07M SEK
Revenue
1.54B
EBIT %
26.82 %
P/E
32.52
Dividend yield-%
3.74 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.5
2026
General meeting '26
7.5
2026
Interim report Q1'26
8.5
2026
Bonus dividend
All
Webcasts
Press releases
ShowingAll content types
BioGaia AB: Year-end report January - December 2025
BioGaia's results for the fourth quarter to exceed market expectations
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
